The Role of RECQ1 in Glioblastoma
Author Information
Author(s): Mendoza-Maldonado Ramiro, Faoro Valentina, Bajpai Sailesh, Berti Matteo, Odreman Federico, Vindigni Marco, Ius Tamara, Ghasemian Abdollah, Bonin Serena, Skrap Miran, Stanta Giorgio, Vindigni Alessandro
Primary Institution: International Centre for Genetic Engineering and Biotechnology
Hypothesis
Is RECQ1 a potential target for anti-cancer therapies in glioblastoma?
Conclusion
RECQ1 is highly expressed in glioblastoma and its depletion significantly reduces tumor cell proliferation.
Supporting Evidence
- RECQ1 is significantly more abundant in glioblastoma tissues compared to perilesional tissues.
- Depletion of RECQ1 leads to reduced cellular proliferation in glioblastoma cell lines.
- RECQ1-depleted glioblastoma cells show increased sensitivity to temozolomide treatment.
- Immunohistochemical analysis confirmed high expression of RECQ1 in glioblastoma compared to normal tissues.
- RECQ1 depletion results in increased DNA damage as indicated by γ-H2AX foci formation.
Takeaway
RECQ1 is a protein that helps glioblastoma cells grow, and if we reduce it, the cancer cells don't grow as well.
Methodology
Immunohistochemical analysis and western blot analysis were used to assess RECQ1 expression in glioblastoma tissues.
Potential Biases
Potential bias in selecting tumor samples from a single institution.
Limitations
The study primarily focuses on glioblastoma and may not generalize to other cancer types.
Participant Demographics
Among the 63 glioblastoma patients, 29 were males with a median age of 65 years and 33 were females with a median age of 62 years.
Statistical Information
P-Value
0.0013
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website